The relation between skin conductance level and plus-maze behavior in male mice

Physiology and Behavior

Volumn 64, Issue 4, 1998, Pages 573-576

  Süer, Cem ^a   Dolu, Nazan ^a   Özesmi, Çigdem ^a   Şahin, Özlem ^a   Ülgen, Ahmet ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Anxiety; Elevated plus maze; Skin conductance

Indexed keywords

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CONDUCTANCE;

EID: 0344972939     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(98)00075-4     Document Type: Article

References (40)

1. Adamec R.E., Sayin U., Brown A. The effects of corticotropin releasing factor (CRF) and handling stress on behavior in the elevated plus-maze test of anxiety. J. Psychopharmacol. 5:1991;175-186.
2. Albus M., Zahn T.P., Breier A. Anxiogenic properties of yohimbine. II. Influence of experimental set and setting. Eur. Arch. Psychiatry Clin. Neurosci. 241:1992;345-351.
3. Ashcroft K.R., Guimarães F.S., Wang M., Deakin J.F. Evaluation of a model of classic fear conditioning in anxious patients. Psychopharmacology (Berl.). 104:1991;215-219.
4. Baldwin H.A., File S.E. Reversal of increased anxiety during benzodiazepine withdrawal Evidence for an anxiojenic endogenous ligand for benzodiazepine receptor . Brain Res. Bull. 20:1988;603-606.
5. 1B characterizing agents in the mouse elevated plus-maze. Life Sci. 47:1990;195-203.
6. Braune S., Albus M., FrÍohler M., Híohn T., Scheibe G. Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal. Eur. Arch. Psychiatry Clin. Neurosci. 244:1994;86-92.
7. Bruce M., Scott N., Shine P., Lader M. Anxiogenic effects of caffeine in patients with anxiety disorders. Arch. Gen. Psychiatry. 49:1992;867-869.
8. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176.
9. Emanuele S., Dale J.A., Klions H.L. Psychology of computer use XLII. Problem solving and humor as a function of computer anxiety . Percept. Mot. Skills. 84:1997;147-156.
10. File S.E. The contribution of behavioral studies to the neuropharmacology of anxiety. Neuropharmacology. 26:1997;877-888.
11. File S.E., Andrews N., Wu P.Y., Zharkovsky A., Zangrossi H. Jr. Modification of clordiazepoxides behavioral and neurochemical effects by handling and plus-maze experience. Eur. J. Pharmacol. 218:1992;9-14.
12. File S.E., Zangrossi H. Jr, Andrews N. Social interaction and elevated plus maze tests: Changes in release and uptake of 5-HT and GABA. Neuropharmacology. 32:1993;217-221.
13. File S.E., Zangrossi H. Jr, Sanders F.L., Mabbutt P.S. Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology (Berl.). 113:1994;543-546.
14. File S.E, Zangrossi H. Jr, Viana M. Trial 2 in the elevated plus-maze A different form of fear? Psychopharmacology (Berl.). 111:1993;491-494.
15. File S.E., Zharkovsky A., Gulati K. Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat. Neuropharmacology. 30:1991;183-190.
16. Gómez-Amor J., Martínez-Selva J.M., Román F., Zamora S., Sastre J.F. Electrodermal activity, hormonal levels and subjective experience during the menstrual cycle. Biol. Psychol. 30:1990;125-139.
17. Gonzalez L.E., Andrews N., File S.E. 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res. 732:1996;145-153.
18. Gonzalez L.E., File S.E. A five-minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J. Neurosci. 17:1997;1505-1511.
19. Ida Y., Tanaka M., Tsuda A., Tsujimasu S., Nagasaki N. Attenuating effect of diazepam on stress-induced increases in noradrenaline turnover in specific brain regions of rats. Antagonism by Ro15-1788. Life Sci. 37:1985;2491-2498.
20. Lader M.H. Palmar skin conductance measures in anxiety and phobic states. J. Abnorm. Psych. 70:1967;442-445.
21. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.). 92:1987;180-185.
22. Lister R.G. Etiologically based animal models of anxiety disorders. Pharmacol. Ther. 46:1990;321-340.
23. Lovibond P.F. Tonic and phasic electrodermal measures of human aversive conditioning with long duration stimuli. Psychophysiology. 29:1992;621-632.
24. Lykken D.T., Venables P.H. Direct measurement of skin conductance A proposal for standardization . Psychophysiology. 8:1971;656-671.
25. Marcy R., Quermonne M.A., Raoul J., Nammathao B., Smida A. Skin Conductance Reaction (SCR)-Habituation Test, a tool to detect anxiolytic activity. Its justification by the correlation between SCR-Habituation Test activities and specific binding potencies in benzodiazepines. Prog. Neuropsychopharmacol. Biol. Psychiat. 9:1985;387-391.
26. Miyamoto M., Kiyota Y., Nishiyama M., Nagaoka A. Senescence-accelerated mouse (SAM) Age-related reduced anxiety-like behavior in the SAM-P/8 strain . Physiol. Behav. 51:1992;979-985.
27. Montgomery K.C. The relation between fear induced by novelty stimulation and exploratory behavior. J. Comp. Physiol. Psychol. 48:1958;254-260.
28. Moser P.C. An evaluation of the elevated plus-maze using the novel anxiolytic buspirone. Psychopharmacology (Berl.). 99:1989;48-53.
29. Ohman A., Soares J.J. Unconscious anxiety Phobic responses to masked stimuli . J. Abnorm. Psychol. 103:1994;231-240.
30. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
31. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects in exploratory activity in an elevated plus-maze A novel test of anxiety in the rat . Pharmacol. Biochem. Behav. 24:1986;525-529.
32. Rodgers R.J., Cole J.C. Anxiety enhancement in the murine elevated plus-maze by immediate prior exposure to social stressors. Physiol. Behav. 53:1993;383-388.
33. Rodgers R.J., Cole J.C., Harrison Phillips D.J. 'Cohort Removal' induces hyperthermia but fails to influence plus-maze behavior in male mice. Physiol. Behav. 55:1994;189-192.
34. Rodgers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethnological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52:1995;297-303.
35. Quermonne M.A., Nammathao B., Louchah[undot]i-Raou I.J., Ma rcy R. Skin conductance reaction-habituation test, an elementary model of anxiety as a tool to assess anxiogenic activities of some drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry. 17:1993;311-318.
36. Steenbergen H.L., Farabollini F., Heinsbroek R.P.W., Van de Pol N.E. Sex-dependent effects of aversive stimulation on haelboard and elevated plus-maze behavior. Behav. Brain Res. 43:1991;159-165.
37. Süer C., Özesmi Ç., Temoçin S., Dogan P., Ciliv G. The effects of immobilization stress on electrodermal activity and brain catecholamine levels in rats. Int. J. Neurosci. 65:1992;91-101.
38. Süer C., Ülgen A., Özesmi Ç., Y[undot]ilmaz A. A technique for measuring computerized skin conductance. Tr. J. Med. Sci. 24:1995;191-194.
39. Valdman A.V., Zaikonnikova I.V., Kozlovskaia M.M., Zimakova I.E. Characteristics of the psychotropic spectrum of action of mebicar. Biull. Eksp. Biol. Med. 89:1980;568-570.
40. Zangrossi H., File S.E. Behavioral consequence in animal tests of anxiety and exploration of exposure to cat odor. Brain Res. Bull. 29:1972;381-388.